The ASEAN rabies veterinary vaccines market is projected to reach USD 46.41 million by the year 2030, demonstrating a compound annual growth rate (CAGR) of 6.73% from 2025 to 2030. The market's expansion is primarily fueled by increasing rabies vaccination coverage among domestic dogs in ASEAN countries, a growing awareness regarding zoonotic diseases (diseases transmissible from animals to humans), and escalating government initiatives aimed at the complete eradication of both animal and human rabies by the end of 2030.

Effective management of rabies within domestic dog populations is paramount for preventing rabies infections in humans, as the majority of documented rabies cases in both animals and humans across ASEAN countries are attributed to dog bites. To successfully prevent and control rabies in both animal and human populations, it is crucial to enhance public awareness about the disease while simultaneously promoting responsible pet ownership and animal welfare practices. Rabies control programs necessitate the consideration of both technical and socio-cultural frameworks. Technical aspects encompass dog population management strategies, comprehensive vaccination programs, adequate diagnostic capabilities, robust disease surveillance programs, and effective control of animal movement. Socio-cultural factors include educating the public about rabies prevention and advocating for ethical pet ownership and animal welfare.

A collaborative framework involving the Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE), the World Health Organization (WHO), and 1 the Global Alliance for Rabies Control (GARC), known as "United Against Rabies," has been established with the ambitious goal of achieving "Zero human rabies deaths by 2030." In conjunction with continuously advocating for stronger actions and greater involvement in the "United Against Rabies" initiative, ASEAN member states will continue to collaborate with these and other partners to prevent human fatalities caused by dog-mediated rabies. Several ASEAN member states are currently facing significant challenges in achieving the targets set forth by The ASEAN Rabies Elimination Strategy (ARES) for the complete eradication of rabies. In the majority of ASEAN countries, rabies remains widespread among dog populations, and bites from rabid dogs are responsible for almost all human cases of the disease within the region. Vaccination of dogs is widely recognized as the most cost-effective method for preventing human rabies infections. 

Curious about the ASEAN Rabies Veterinary Vaccines Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

ASEAN Rabies Veterinary Vaccines Market Report Highlights include:

• The companion animals segment accounted for the largest revenue share, exceeding 95.0% in 2024, and is anticipated to grow at the fastest CAGR over the forecast period. This dominance reflects the primary focus of rabies vaccination efforts on domestic pets, particularly dogs and cats, due to their close interaction with humans.

• The hospital/clinical pharmacy segment represented the largest distribution channel, accounting for a revenue share of over 45.0% in 2024. This indicates that a significant portion of rabies vaccines for animals is currently distributed through traditional veterinary healthcare settings.

• The e-commerce segment is anticipated to grow at the fastest CAGR over the forecast period. This rapid growth is attributed to the increasing trend of utilizing digital platforms for purchasing veterinary products and the growing adoption of online channels by pet owners due to their convenience and accessibility.

• The Thailand market is anticipated to grow at a significant CAGR over the forecast period, indicating a focused effort and increasing demand for rabies veterinary vaccines within this specific ASEAN member state.

List of Key Players in ASEAN Rabies Veterinary Vaccines Market

• Boehringer Ingelheim International GmbH

• Zoetis

• Merck & Co., Inc.

• Virbac

• Indian Immunologicals Ltd.

• BroadChem Philippines Biopharma Corporation

Order a free sample PDF of the ASEAN Rabies Veterinary Vaccines Market Intelligence Study, published by Grand View Research.